ATE1949T1 - Komplexe von 9-hydroxyalkylpurinen, verfahren zu ihrer herstellung und diese komplexe als aktive mittel enthaltende therapeutische zusammensetzungen. - Google Patents

Komplexe von 9-hydroxyalkylpurinen, verfahren zu ihrer herstellung und diese komplexe als aktive mittel enthaltende therapeutische zusammensetzungen.

Info

Publication number
ATE1949T1
ATE1949T1 AT79103232T AT79103232T ATE1949T1 AT E1949 T1 ATE1949 T1 AT E1949T1 AT 79103232 T AT79103232 T AT 79103232T AT 79103232 T AT79103232 T AT 79103232T AT E1949 T1 ATE1949 T1 AT E1949T1
Authority
AT
Austria
Prior art keywords
complexes
activity
hydroxyalkylpurines
preparation
active agents
Prior art date
Application number
AT79103232T
Other languages
English (en)
Inventor
Lionel Norton Simon
John Winthrop Hadden
Original Assignee
Newport Pharmaceuticals International, Inc.
Sloan-Kettering Institute For Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Newport Pharmaceuticals International, Inc., Sloan-Kettering Institute For Cancer Research filed Critical Newport Pharmaceuticals International, Inc.
Application granted granted Critical
Publication of ATE1949T1 publication Critical patent/ATE1949T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/36—Sulfur atom
    • C07D473/38—Sulfur atom attached in position 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
AT79103232T 1978-09-15 1979-08-31 Komplexe von 9-hydroxyalkylpurinen, verfahren zu ihrer herstellung und diese komplexe als aktive mittel enthaltende therapeutische zusammensetzungen. ATE1949T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/942,802 US4221909A (en) 1978-09-15 1978-09-15 P-Acetamidobenzoic acid salts of 9-(hydroxyalkyl) purines
EP79103232A EP0009154B1 (de) 1978-09-15 1979-08-31 Komplexe von 9-Hydroxyalkylpurinen, Verfahren zu ihrer Herstellung und diese Komplexe als aktive Mittel enthaltende therapeutische Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE1949T1 true ATE1949T1 (de) 1982-12-15

Family

ID=25478620

Family Applications (1)

Application Number Title Priority Date Filing Date
AT79103232T ATE1949T1 (de) 1978-09-15 1979-08-31 Komplexe von 9-hydroxyalkylpurinen, verfahren zu ihrer herstellung und diese komplexe als aktive mittel enthaltende therapeutische zusammensetzungen.

Country Status (27)

Country Link
US (1) US4221909A (de)
EP (1) EP0009154B1 (de)
JP (1) JPS5547683A (de)
KR (1) KR840000552A (de)
AT (1) ATE1949T1 (de)
AU (1) AU527851B2 (de)
CA (1) CA1122217A (de)
CS (1) CS251060B2 (de)
DD (1) DD146049A5 (de)
DE (1) DE2964211D1 (de)
DK (1) DK149857C (de)
ES (1) ES484167A1 (de)
FI (1) FI68234C (de)
GR (1) GR74076B (de)
HU (1) HU182544B (de)
IE (1) IE48827B1 (de)
IL (1) IL58087A (de)
IN (1) IN153099B (de)
MX (1) MX6521E (de)
NO (1) NO152445C (de)
NZ (1) NZ191483A (de)
PH (1) PH16315A (de)
PL (2) PL124515B1 (de)
PT (1) PT70180A (de)
RO (1) RO77565A (de)
YU (1) YU41884B (de)
ZA (1) ZA793973B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4340726A (en) * 1980-03-14 1982-07-20 Newport Pharmaceuticals International, Inc. Esters
US4451478A (en) * 1982-03-12 1984-05-29 Newport Pharmaceuticals International, Inc. Imidazole compounds
US5147636A (en) * 1982-11-09 1992-09-15 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives and interferons
US4849411A (en) * 1982-11-09 1989-07-18 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
HUT36464A (en) * 1983-05-24 1985-09-30 Newport Pharmaceuticals Process for producing erythro-4-amino-3-/2-hydroxy-3-alkyl/-imidazol-5-carboxamide
IT1215339B (it) * 1987-01-14 1990-02-08 Co Pharma Corp Srl Procedimento per la preparazione di 9-(idrossialchil)-ipoxantine
US5091432A (en) * 1990-03-28 1992-02-25 Glasky Alvin J 9-substituted hypoxanthine bi-functional compounds and their neuroimmunological methods of use
US5614504A (en) * 1990-08-01 1997-03-25 The University Of South Florida Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
JPH10504814A (ja) 1994-07-25 1998-05-12 ジェイ． グラスキー，アルヴィン 一酸化炭素依存性グアニリルシクラーゼ修飾因子
AU5522996A (en) * 1996-02-12 1997-08-28 Cypros Pharmaceutical Corporation Hydroxynonyladenine analogs with enhanced lipophilic and anti-ischemic traits
AU3786299A (en) 1998-05-04 1999-11-23 Neotherapeutics, Inc. Novel serotonin-like 9-substituted hypoxanthine and methods of use
US6297226B1 (en) 1999-10-15 2001-10-02 Neotherapeutics, Inc. Synthesis and methods of use of 9-substituted guanine derivatives
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
DK1790344T3 (da) 2000-07-07 2011-05-02 Spectrum Pharmaceuticals Inc Fremgangsmåder til behandling af sygdomsfremkaldt perifer neuropati og beslægtede tilstande
US6759427B2 (en) * 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
CA2540598C (en) * 2003-10-03 2013-09-24 3M Innovative Properties Company Pyrazolopyridines and analogs thereof
WO2005074946A1 (en) * 2004-02-10 2005-08-18 Adenobio N.V. Stable and active complexes of adenosine and adenosine phosphates with aminoalcohols for the treatment of pulmonary artery hypertension, cardiac failure and other diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3215696A (en) * 1965-11-02 Substituted adenines -and preparation thereof
US3728450A (en) * 1969-08-28 1973-04-17 Newport Pharmaceuticals Inosine derivatives
BE755361A (fr) * 1969-08-28 1971-03-01 Newport Pharmaceuticals Derives de l'inosine
US3857940A (en) * 1971-05-21 1974-12-31 Newport Pharmaceuticals Inosine derivatives
US3836656A (en) * 1972-02-07 1974-09-17 Sandoz Ag Substituted purines as hypolipidemics
US3862189A (en) * 1973-08-14 1975-01-21 Warner Lambert Co Aralkyl-substituted purines and pyrimidines as antianginal bronchodilator agents
US4060616A (en) * 1976-03-01 1977-11-29 Burroughs Wellcome Co. Purine derivatives with repeating unit
YU96177A (en) * 1976-04-24 1982-08-31 Wuelfing Johann A Process for obtaining adenine derivatives

Also Published As

Publication number Publication date
NO792792L (no) 1980-03-18
IL58087A (en) 1983-03-31
IN153099B (de) 1984-06-02
ZA793973B (en) 1980-09-24
JPH031309B2 (de) 1991-01-10
FI68234C (fi) 1985-08-12
NZ191483A (en) 1983-06-14
HU182544B (en) 1984-02-28
FI68234B (fi) 1985-04-30
ES484167A1 (es) 1980-09-01
YU224579A (en) 1983-12-31
PL119685B1 (en) 1982-01-30
DE2964211D1 (en) 1983-01-13
PL124515B1 (en) 1983-01-31
NO152445C (no) 1985-10-02
EP0009154B1 (de) 1982-12-08
NO152445B (no) 1985-06-24
KR840000552A (ko) 1984-02-25
FI792849A (fi) 1980-03-16
JPS5547683A (en) 1980-04-04
RO77565A (ro) 1981-11-04
MX6521E (es) 1985-06-27
DK385679A (da) 1980-03-16
YU41884B (en) 1988-02-29
CA1122217A (en) 1982-04-20
DK149857C (da) 1987-03-02
PH16315A (en) 1983-09-05
EP0009154A1 (de) 1980-04-02
IE791753L (en) 1980-03-15
AU527851B2 (en) 1983-03-24
AU5055779A (en) 1980-03-20
CS251060B2 (en) 1987-06-11
PL218317A1 (de) 1980-06-16
DK149857B (da) 1986-10-13
GR74076B (de) 1984-06-06
PT70180A (en) 1979-10-01
DD146049A5 (de) 1981-01-21
IE48827B1 (en) 1985-05-29
US4221909A (en) 1980-09-09

Similar Documents

Publication Publication Date Title
ATE1949T1 (de) Komplexe von 9-hydroxyalkylpurinen, verfahren zu ihrer herstellung und diese komplexe als aktive mittel enthaltende therapeutische zusammensetzungen.
ATE1814T1 (de) 9-hydroxyalkylpurine, verfahren zu ihrer herstellung und 9-hydroxyalkylpurine als aktive mittel enthaltende therapeutische zusammensetzung.
ATE32512T1 (de) Piperazinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3363244D1 (en) Compounds, process for their preparation and their use as pharmaceutical preparations
ATE14579T1 (de) Pharmazeutische heterocyclische verbindungen, verfahren zu ihrer herstellung und sie enthaltende zusammensetzungen.
ATE41772T1 (de) Polymethoxybenzyl-piperazin-derivate, verfahren zu ihrer herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen.
ES528462A0 (es) Procedimiento de preparacion de nuevos derivados dialquilaminoalcoxibencilalcoholicos y de sus sales de adicion acidas y amonicas cuaternarias
JPS6431752A (en) Amide derivative and skin external preparation containing said derivative
ES8106147A1 (es) Procedimiento para preparar un 1,2,4-triazol-3-tiol
GR3007410T3 (de)
ATE19879T1 (de) Furyloxazolylessigsaeure-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
GB2175584A (en) Kojic acid derivatives and whitening cosmetics containing same
JPS55309A (en) N,n'-substituted-paraphenylenediamine derivative, its preparation, and rubber composition containing above derivative as antioxidant
ATE18223T1 (de) Ergolinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
GB1545077A (en) Process for purifying water using bis-isothiouronium salts
ATE82289T1 (de) 1-hydroxyalkylxanthine, verfahren zu ihrer herstellung und sie enthaltende medikamente.
GB2011399A (en) Bactericidal compositions
GB2022075A (en) Lactam-N-acetic acids and the preparation thereof
SE8300686L (sv) Herbicidala kompositioner

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee